ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 763621 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 763621; 2) Community: the network communities that were significantly associated with the response to NSC 763621; 3) Molecule: the relationships between components within communities and NSC 763621; 4) MDR: the compounds that were significantly associated with the NSC 763621.

NSC Compound Enrichment Correlation
NSC 717468 Null 0.0392716453377535 0.18102829
NSC 718564 Null 0.0392716453377535 0.03765927
NSC 726089 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate 0.0392716453377535 0.18306442
NSC 726217 Combretastatin A4-analogue 0.0392716453377535 0.36596873
NSC 726442 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride 0.0392716453377535 0.19743486
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.0392716453377535 0.27939304
NSC 744688 Null 0.0392716453377535 0.4838818
NSC 751042 Null 0.0392716453377535 0.38811132
NSC 753661 methyl ester prodigiosene 0.0392716453377535 0.45273175
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0392716453377535 0.45814066
Total:104  Current:88    [First] [Prev] [Next] [Last]